‘Swaasa,’ an AI-driven software, can assess if human lungs are abnormal when a user coughs thrice near the phone. Swaasa was developed by Hyderabad-based Salcit Technologies and won the Anjani Mashelkar award for innovation in November.
Salcit founder Narayana Rao Sripada’s discussion with a professor at AIIMS five years ago was the origin of this innovation. It was then he realized the need for devices to diagnose lung health in the medical sector in real-time with non-invasive technology.
It took three years until Swaasa was ready to roll out. A discussion on how there is an immediate need for such a technology that is non-invasive and can help identify a problem was the origin of Swaasa.
Read More: Microsoft India And LinkedIn Announce The Skill For Jobs Program
“If it can be attributed to lung parenchyma or lung airways, that itself can be of major value for the health worker to initiate an apt intervention,” said Narayana Rao.
This poses a challenge in rural areas, where access to medical care and diagnostics labs is not guaranteed. Swaasa eliminates all of these issues, said Manmohan Jain, Chief Operating Officer of Salcit.
